Rational Identification of Enoxacin as a Novel V-ATPase-Directed Osteoclast Inhibitor

Current Protein and Peptide Science- United Arab Emirates

doi 10.2174/138920312800493151

Full Text

Abstract

Available in

Categories

Molecular Biology

Date

April 1, 2012

Authors

Edgardo J. Toro

David A. Ostrov

Thomas J. Wronski

L. Shannon Holliday

Publisher

Bentham Science Publishers Ltd.

Related search

Effects of Diphyllin as a Novel V-ATPase Inhibitor on TE-1 and ECA-109 Cells

Oncology Reports

Cancer Research

English

Identification of Cystatin SA as a Novel Inhibitor of Acid Ceramidase

Journal of Biological Chemistry

Molecular Biology

English

Site-Directed Mutagenesis of the Yeast V-ATPase B Subunit (Vma2p)

Journal of Biological Chemistry

Molecular Biology

English

Diphyllin, a Novel and Naturally Potent V-ATPase Inhibitor, Abrogates Acidification of the Osteoclastic Resorption Lacunae and Bone Resorption

Journal of Bone and Mineral Research

Sports Medicine

English

Identification of a Novel Potential Antitumor Activity of Gossypol as an APE1/Ref-1 Inhibitor

Drug Design, Development and Therapy

Pharmaceutical Science

English

Sphingosylphosphorylcholine as a Novel Calmodulin Inhibitor

Biochemical Journal

Molecular Biology

English

Identification of Myricetin as Ebolavirus VP35-dsRNA Interaction Inhibitor Through a Novel Fluorescence-Based Assay

English

Identification of Mannich Base as a Novel Inhibitor of Mycobacterium Tuberculosis Isocitrate by High-Throughput Screening

International Journal of Biological Sciences

Applied Microbiology

Developmental Biology

Molecular Biology

English

Identification of Capsazepine as a Novel Inhibitor of System Xc− And Cancer-Induced Bone Pain

Journal of Pain Research

English